Delirium
Current study results on the use of virtual reality for relaxation and distraction in intensive care unit (ICU) patients have been published. The study, conducted by researchers at Aarhus University Hospital, aimed to identify and adapt a virtual reality intervention to meet the specific needs of patients admitted to an
Nervous system diseases
A study published in BMC Pediatrics has shown that intraoperative dexmedetomidine significantly reduces the incidence of postoperative delirium (POD) in pediatric patients undergoing lower extremity orthopedic surgery. The research, conducted at Children's Hospital of Jiangnan University in Wuxi, China, included 128 pediatric patients aged 3-12 years who underwent
Nervous system diseases
New research conducted at Cedars-Sinai Medical Center in Los Angeles, California, reveals that antimicrobial treatment can alleviate delirium-like symptoms in mice induced with urinary tract infections (UTI). The study, published in Translational Psychiatry, suggests that this finding could have significant implications for the treatment of delirium in humans, particularly in
Nervous system diseases
In a study published in the European Geriatric Medicine journal, researchers from the Department of Geriatric Medicine aimed to investigate the effectiveness of combining the 4AT and SQiD tools for detecting delirium in hospitalized older patients. Despite the promising results of the SQiD tool, which has a high negative predictive
Nervous system diseases
Recent research has shed light on the incidence and risk factors of postoperative delirium in surgical patients. According to a study published in the Journal of Clinical Anesthesia, postoperative delirium is a preventable complication that can increase morbidity, mortality, hospital stays, and costs. The study, conducted in 43 Spanish hospitals,
Nervous system diseases
Researchers from the National Cancer Center Hospital in Tokyo, Japan, have reported a case study and literature review highlighting the potential effectiveness of yokukansan and lemborexant as alternative candidates to benzodiazepines in preventing benzodiazepine withdrawal delirium in the cancer perioperative period. The study involved a patient who had been receiving
